Talniflun 370 mg Tablets (Talniflumate)

Adult dose

Administer talniflumate 370 mg orally 3 times daily. For severe cases, administer 740 mg per dose. The dose may be adjusted as appropriate according to age and symptoms.

This medicine may increase the risk of stomach bleeding if taken by individuals who regularly consume more than three alcoholic drinks each day; it is essential to consult a doctor or pharmacist. As a non-steroidal anti-inflammatory drug, patients with cardiovascular diseases or risk factors are at higher risk for serious cardiovascular issues like myocardial infarction or stroke and should exercise caution. Moreover, significant gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforations may occur, particularly in those with a history of gastrointestinal diseases or in the elderly. This drug should not be administered to patients with a history of peptic ulcers or hypersensitivity to the drug, severe liver, kidney, or heart diseases, pregnant or nursing women, and certain genetically predisposed lactose-intolerant patients. Caution should be exercised in administering it to patients with mild to moderate liver, kidney, or heart impairment, elderly patients, or those on diuretics, as well as patients with allergy to Yellow No. 5. Various side effects like nausea, vomiting, diarrhea, abdominal pain, skin rash, dizziness, and renal function abnormalities may occur; therefore, if any abnormal symptoms arise, immediate consultation with a healthcare provider is necessary. This medication should be used at the minimum effective dose for the shortest duration, and regular blood tests and monitoring of liver and kidney function are required for long-term use. It may interact with other anti-inflammatory drugs, certain blood pressure medications, diuretics, anticoagulants, lithium, methotrexate, etc., so if there are other medications being taken, they must be disclosed. It should not be used during pregnancy, particularly in the third trimester, due to potential risks to the fetus, and during lactation, the safety is not established, so it is recommended to either discontinue breastfeeding or stop the medication. It is not to be used in children under 12 years of age, and elderly patients should take it with caution, using the minimum effective dose. This medication should be stored out of the reach of children and should not be transferred to other containers.

• nausea
• vomiting
• photosensitivity
• asthma attack
• hypotension
• generalized weakness
• hypersensitivity shock
• diarrhea
• abdominal distension
• constipation

This medication should be stored in a tightly sealed container to prevent air exposure, at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain its efficacy for a longer time.

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle